David Picard
Chief Executive Officer

David co-founded Moleac and is serving as CEO since. Over the past years David has structured the team, identified key products as well as the scientific, clinical, and business partners in China, Singapore and Europe, and implemented the business agreements.
Prior to founding Moleac, David has spent ten years at The Boston Consulting Group ("BCG") where he was a member of the worldwide Health Care Practice Area. He has worked both in Europe and in Asia. He has extensive experience in working in Greater China and in Korea.

David graduated from the two top engineering schools in France, Ecole Polytechnique and Ecole Nationale Supérieure des Mines de Paris, where he majored in mathematics and economics. David also holds a French degree ("DESS") in business law.

Bounmy Rattanavan
Co-Founder and Non-Executive Director

Bounmy, a French national of Chinese origin, co-founded Tang Frères with his brother. Tang Frères started twenty five years ago as the leading Asian food import/export business in France.  Through Tang Frères, Bounmy has established an influential network in Europe and in China which has positioned him to be the partner of choice to several multinationals wanting to build and expand business in China. Bounmy has developed many businesses between Europe and China and is active in industries such as biotechnology, enzymes, retailing, media, food, ...

Bounmy co-founded Moleac and contributes his strong entrepreneurial experience in Europe and in China, and his valuable knowledge of China scientific academies and regulatory system.

Marc Vasseur
Co-Founder and Chairman of the Board

In 1989, Marc co-founded Genset and has been board member, Chief Biology Officer and General Manager of the company until 2000.. Marc left Genset from July 2000 to March 2002. During this period, he was involved in the launch of a number of biotechnology companies spinning off from the Pasteur Institute. He came back to Genset in March 2002 and was appointed CEO and Chairman. He has managed the acquisition of Genset by Serono through a tender offer. Marc then served as the CEO and Chairman of Serono France Holding. He recently created a new venture Sobios (Sophia Bio System) in France. Marc has also served as a Director of several other biotechnology companies, and actively participates and has participated in advisory boards of several investment funds. Before launching Genset, Marc had been a director of biological research at L'Oreal, after working 10 years at the Pasteur Institute. Marc Vasseur is a former Professor of Virology at the University of Paris, and has taught in many universities world-wide, including Zhonshan University in Guangzhou.

Marc co-founded Moleac, he contributes considerable experience and knowledge in research management, clinical and regulatory strategies Intellectual Property management and business development.

Non-Executive Director

Christophe Polini is the Company General Secretary of Tang Frères, where he has worked for more than a decade, first as legal director and since 2000 as its General Secretary. Christophe holds a Master in Laws and has worked in law firms and as the legal director of Afflelou. Christophe brings to Moleac a strong experience of structuring and managing partnerships in China.

Gerard Tardy
Non-Executive Director

Gérard is a graduate of HEC Paris and attended the business management programme of Stanford University (USA). He is a currently Director of Merieux Development. Prior to this, he was an investment manager at Elf Technology in Paris and San Francisco in the early 1980’s. He founded and became CEO of Citicorp Venture Capital in Paris in 1984 and subsequently founded Schroder Ventures Paris (1989-1997). He has been responsible for four Venture and Buy out Funds, investing in total 200 M €, including 12 investments in the healthcare sector. He was also a Director of the French Venture Capital Association (AFIC). Gérard relocated to London in 1997 as a Director of Schroder Ventures Europe (now Permira). He founded Sitka Ltd in March 1999 and the Sitka Health Fund VCT plc in 2001 which he sold to NFM in November 2005. Gerard is a Board member of several UK and French companies.He has been nominated Conseiller du Commerce Exterieur in March 2007.

Email Print PDF